Eye-Tracking tech could revolutionize MS monitoring

NCT ID NCT06733922

Recruiting now Knowledge-focused Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Oct 31, 2025 · Last updated May 14, 2026 · Updated 28 times

Summary

This study looks at whether tracking eye movements can help doctors see how well multiple sclerosis (MS) treatment is working. About 224 Canadian adults with relapsing-remitting MS who are starting the drug ofatumumab will have their eye movements measured over time. The goal is to find a simple, non-invasive way to monitor the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Locations

Novartis Investigative Site
RECRUITING

Calgary, Alberta, T2N 4N1, Canada
Novartis Investigative Site
RECRUITING

Calgary, Alberta, T3M 1M4, Canada
Novartis Investigative Site
RECRUITING

Edmonton, Alberta, T6G 2C8, Canada
Novartis Investigative Site
RECRUITING

Burnaby, British Columbia, V5G 2X6, Canada
Novartis Investigative Site
RECRUITING

Vancouver, British Columbia, V6T 2A1, Canada
Novartis Investigative Site
RECRUITING

St. John's, Newfoundland and Labrador, A1B 3V6, Canada
Novartis Investigative Site
RECRUITING

Halifax, Nova Scotia, B3H 3A7, Canada
Novartis Investigative Site
RECRUITING

Halifax, Nova Scotia, B3R 1V9, Canada
Novartis Investigative Site
RECRUITING

Ottawa, Ontario, K1H 8L6, Canada
Novartis Investigative Site
RECRUITING

Montreal, Quebec, H1K 3V9, Canada
Novartis Investigative Site
RECRUITING

Montreal, Quebec, H3A 0G4, Canada
Novartis Investigative Site
RECRUITING

Montreal, Quebec, H4A 3T2, Canada
Novartis Investigative Site
RECRUITING

Québec, Quebec, G1W 4R4, Canada
Novartis Investigative Site
RECRUITING

Sherbrooke, Quebec, J1G 2E8, Canada

Conditions

Explore the condition pages connected to this study.

RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS)